Ligand Pharmaceuticals Lowered to "Sell" at Cantor Fitzgerald

Home › Ligand Pharmaceuticals Lowered to "Sell" at Cantor Fitzgerald

They currently have a $37.00 price objective on the stock, up from their previous price objective of $36.00.

01.07	Atlantic Tropical Weather Outlook
01.07	Hurricane Beryl Graphics
01.07	Hurricane Beryl Public Advisory Number 9A
01.07	Summary for Hurricane Beryl (AT2/AL022024)
01.07	Tropical Depression Three Graphics
01.07	Tropical Depression Three Public Advisory Number 1A
01.07	Summary for Tropical Depression Three (AT3/AL032024)
01.07	Eastern North Pacific Tropical Weather Outlook
More »

je.st